BEAM
Price
$30.43
Change
-$2.71 (-8.18%)
Updated
Feb 21 closing price
Capitalization
2.52B
10 days until earnings call
NTLA
Price
$12.17
Change
-$0.08 (-0.65%)
Updated
Feb 21 closing price
Capitalization
1.24B
68 days until earnings call
Ad is loading...

BEAM vs NTLA

Header iconBEAM vs NTLA Comparison
Open Charts BEAM vs NTLABanner chart's image
Beam Therapeutics
Price$30.43
Change-$2.71 (-8.18%)
Volume$1.88M
Capitalization2.52B
Intellia Therapeutics
Price$12.17
Change-$0.08 (-0.65%)
Volume$4.45M
Capitalization1.24B
BEAM vs NTLA Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. NTLA commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and NTLA is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 22, 2025
Stock price -- (BEAM: $33.14 vs. NTLA: $12.25)
Brand notoriety: BEAM and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 102% vs. NTLA: 153%
Market capitalization -- BEAM: $2.52B vs. NTLA: $1.24B
BEAM [@Biotechnology] is valued at $2.52B. NTLA’s [@Biotechnology] market capitalization is $1.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while NTLA’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • NTLA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than NTLA.

Price Growth

BEAM (@Biotechnology) experienced а +15.83% price change this week, while NTLA (@Biotechnology) price change was +27.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +3.87%, and the average quarterly price growth was +3.11%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

NTLA is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.52B) has a higher market cap than NTLA($1.24B). BEAM YTD gains are higher at: 33.629 vs. NTLA (5.060). BEAM has higher annual earnings (EBITDA): -160.83M vs. NTLA (-527.52M). BEAM has more cash in the bank: 926M vs. NTLA (658M). NTLA has less debt than BEAM: NTLA (102M) vs BEAM (162M). BEAM has higher revenues than NTLA: BEAM (350M) vs NTLA (43.1M).
BEAMNTLABEAM / NTLA
Capitalization2.52B1.24B203%
EBITDA-160.83M-527.52M30%
Gain YTD33.6295.060665%
P/E RatioN/AN/A-
Revenue350M43.1M812%
Total Cash926M658M141%
Total Debt162M102M159%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMNTLA
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 12 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GIXIX9.28N/A
N/A
Nationwide International Index R6
NVSOX13.47N/A
N/A
Allspring Disciplined Small Cap Adm
SSDAX32.72N/A
N/A
DWS Small Cap Growth A
AGWUX62.30N/A
N/A
American Century Growth R5
TIOVX15.64N/A
N/A
Nuveen International Opps W

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-2.79%
CRSP - BEAM
70%
Closely correlated
-4.88%
NTLA - BEAM
61%
Loosely correlated
-0.24%
DNLI - BEAM
57%
Loosely correlated
-2.88%
PRME - BEAM
57%
Loosely correlated
-4.72%
AXON - BEAM
57%
Loosely correlated
-8.70%
More